D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 56 Citations 10,724 155 World Ranking 9960 National Ranking 181

Overview

What is she best known for?

The fields of study she is best known for:

  • Enzyme
  • Internal medicine
  • Amino acid

Her primary scientific interests are in Dipeptidyl peptidase, Biochemistry, Molecular biology, Chemokine and Dipeptidyl peptidase-4. Her Dipeptidyl peptidase research incorporates elements of Oligopeptidase, Endocrinology, In vitro and Internal medicine. Her Molecular biology study combines topics from a wide range of disciplines, such as CC chemokine receptors, T cell and CXCL2.

Her Chemokine research includes themes of Biological activity and Chemotaxis. The various areas that she examines in her Dipeptidyl peptidase-4 study include Neuropeptide, Neuropeptide Y receptor and Renal ischemia. Her studies in Protease integrate themes in fields like Dipeptidyl peptidase 8, Chemokine receptor and Protein tyrosine phosphatase.

Her most cited work include:

  • Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. (697 citations)
  • The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety (612 citations)
  • CD26, let it cut or cut it down (421 citations)

What are the main themes of her work throughout her whole career to date?

The scientist’s investigation covers issues in Dipeptidyl peptidase, Biochemistry, Internal medicine, Dipeptidyl peptidase-4 and Enzyme. Her Dipeptidyl peptidase study focuses on Dipeptidyl-peptidase II in particular. Her Biochemistry study frequently draws connections between adjacent fields such as Fibroblast activation protein, alpha.

Within one scientific family, Ingrid De Meester focuses on topics pertaining to Endocrinology under Internal medicine, and may sometimes address concerns connected to Vasoactive intestinal peptide and Transplantation. Her work in Dipeptidyl peptidase-4 covers topics such as Protease which are related to areas like Cell biology. Her Enzyme research integrates issues from Dipeptidyl Peptidase 9, Dipeptidyl peptidase 8, Chemical synthesis and Stereochemistry.

She most often published in these fields:

  • Dipeptidyl peptidase (42.33%)
  • Biochemistry (33.74%)
  • Internal medicine (22.70%)

What were the highlights of her more recent work (between 2013-2021)?

  • Immunology (11.04%)
  • Dipeptidyl peptidase (42.33%)
  • Internal medicine (22.70%)

In recent papers she was focusing on the following fields of study:

Ingrid De Meester mainly focuses on Immunology, Dipeptidyl peptidase, Internal medicine, Fibroblast activation protein, alpha and Dipeptidyl peptidase-4. Her Immunology research incorporates themes from Proteases, Disease and Transplantation. Her research in Dipeptidyl peptidase intersects with topics in Cancer research, CXCL10, Extracellular matrix, Structure–activity relationship and Type 2 diabetes.

Ingrid De Meester combines subjects such as Gastroenterology and Diabetes mellitus, Endocrinology with her study of Internal medicine. Her Dipeptidyl peptidase-4 research includes elements of Porphyromonas gingivalis, Pharmacokinetics, In vitro and Microbiology. Her Serine protease research is included under the broader classification of Biochemistry.

Between 2013 and 2021, her most popular works were:

  • The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis. (80 citations)
  • Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP) (70 citations)
  • Left ventricular diastolic dysfunction and myocardial stiffness in diabetic mice is attenuated by inhibition of dipeptidyl peptidase 4. (51 citations)

In her most recent research, the most cited papers focused on:

  • Enzyme
  • Internal medicine
  • Amino acid

Her primary areas of study are Dipeptidyl peptidase, Immunology, Dipeptidyl peptidase-4, In vitro and Antibody. Ingrid De Meester combines subjects such as Cancer research and Type 2 diabetes with her study of Dipeptidyl peptidase. Her Immunology research incorporates elements of Disease and Transplantation.

Her Dipeptidyl peptidase-4 study integrates concerns from other disciplines, such as Interleukin 6, Oligopeptidase, Structure–activity relationship and Macrophage. Her Oligopeptidase study is concerned with the field of Biochemistry as a whole. Her In vitro research includes themes of Porphyromonas gingivalis, Periodontitis and Microbiology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.

Anne-Marie Lambeir;Christine Durinx;Simon Scharpé;Ingrid De Meester.
Critical Reviews in Clinical Laboratory Sciences (2003)

1171 Citations

The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety

Michael Maes;Cai Song;Aihua Lin;Raf De Jongh.
Cytokine (1998)

906 Citations

CD26, let it cut or cut it down

Ingrid De Meester;Stephan Korom;Stephan Korom;Jo Van Damme;Simon Scharpé.
Immunology Today (1999)

661 Citations

Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.

Paul Proost;Ingrid De Meester;Dominique Schols;Sofie Struyf.
Journal of Biological Chemistry (1998)

398 Citations

Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides.

Christine Durinx;Anne-Marie Lambeir;Eugène Bosmans;Jean-Bernard Falmagne.
FEBS Journal (2000)

367 Citations

Kinetic Investigation of Chemokine Truncation by CD26/Dipeptidyl Peptidase IV Reveals a Striking Selectivity within the Chemokine Family

Anne-Marie Lambeir;Paul Proost;Christine Durinx;Gunther Bal.
Journal of Biological Chemistry (2001)

329 Citations

Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1α

Paul Proost;Sofie Struyf;Dominique Schols;Christine Durinx.
FEBS Letters (1998)

284 Citations

Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form.

Inger Brandt;Anne-Marie Lambeir;Jean-Marie Ketelslegers;Marc Vanderheyden.
Clinical Chemistry (2006)

255 Citations

Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist.

Paul Proost;Patricia Menten;Sofie Struyf;Evemie Schutyser.
Blood (2000)

222 Citations

Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor.

Sofie Struyf;Ingrid De Meester;Simon Scharpé;Jean-Pierre Lenaerts.
European Journal of Immunology (1998)

207 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Ingrid De Meester

Mark D. Gorrell

Mark D. Gorrell

University of Sydney

Publications: 58

Hans-Ulrich Demuth

Hans-Ulrich Demuth

Fraunhofer Society

Publications: 55

Michael Maes

Michael Maes

Chulalongkorn University

Publications: 52

Paul Proost

Paul Proost

KU Leuven

Publications: 50

Chikao Morimoto

Chikao Morimoto

Juntendo University

Publications: 47

Sofie Struyf

Sofie Struyf

KU Leuven

Publications: 39

Dirk Reinhold

Dirk Reinhold

Otto-von-Guericke University Magdeburg

Publications: 34

Geoffrey W. McCaughan

Geoffrey W. McCaughan

University of Sydney

Publications: 32

Simon Scharpé

Simon Scharpé

University of Antwerp

Publications: 31

Siegfried Ansorge

Siegfried Ansorge

Otto-von-Guericke University Magdeburg

Publications: 31

Adrian Covaci

Adrian Covaci

University of Antwerp

Publications: 26

Daniel J. Drucker

Daniel J. Drucker

Lunenfeld-Tanenbaum Research Institute

Publications: 25

Richard D. DiMarchi

Richard D. DiMarchi

Indiana University

Publications: 24

Jo Van Damme

Jo Van Damme

Rega Institute for Medical Research

Publications: 23

Anne-Marie Lambeir

Anne-Marie Lambeir

University of Antwerp

Publications: 22

Matthew L. Albert

Matthew L. Albert

Genentech

Publications: 20

Trending Scientists

Ishfaq Ahmad

Ishfaq Ahmad

The University of Texas at Arlington

Boris Mizaikoff

Boris Mizaikoff

University of Ulm

Antonio Guerrero-Ruiz

Antonio Guerrero-Ruiz

National University of Distance Education

Geoffrey C. Maitland

Geoffrey C. Maitland

Imperial College London

Avraham A. Levy

Avraham A. Levy

Weizmann Institute of Science

Arthur W. Nienhuis

Arthur W. Nienhuis

St. Jude Children's Research Hospital

Michael Power

Michael Power

University of Waterloo

Knut Kielland

Knut Kielland

University of Alaska Fairbanks

Antoine Tesniere

Antoine Tesniere

Université Paris Cité

Paul Christakopoulos

Paul Christakopoulos

Luleå University of Technology

Douglas B. Clark

Douglas B. Clark

UK Centre for Ecology and Hydrology

Peter Ward

Peter Ward

University of Washington

Daniël H. J. Wigboldus

Daniël H. J. Wigboldus

Radboud University Nijmegen

E. Scott Huebner

E. Scott Huebner

University of South Carolina

Costan W. Berard

Costan W. Berard

St. Jude Children's Research Hospital

Cathy D. Schleck

Cathy D. Schleck

Mayo Clinic

Something went wrong. Please try again later.